 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Advanced Tissue Sciences, Inc.
 |
Advanced Tissue Sciences, Inc. |
 |
 |
 |
PROFILE |
 |
To Advanced Tissue Sciences, tissue repair doesn't involve reusing Kleenex. The company engineers living human cells into replacement tissue to repair damaged skin. Its products include TransCyte, a temporary burn treatment approved by the FDA, and Dermagraft, a human skin replacement for treating diabetes-related foot sores approved in Canada, Australia, the UK, and several other European countries. Other applications for the company's technology in research and development include facial and reconstructive surgery, orthopedics, and the regeneration of blood vessels. TransCyte and Dermagraft are marketed through a joint venture with British medical products company Smith & Nephew.
COMPETITION |
 |
Genzyme Biosurgery (GZBX)
Integra LifeSciences Holdings Corporation (IART)
LifeCell Corporation (LIFC)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 25.30
1-Yr. Sales Growth: (40.9)%
Employees: 192
Revenue per employee: $131,770.83
KEY PEOPLE |
 |
Arthur J. Benvenuto
CEO
Nikhil A. Mehta
CFO
CONTACT INFO |
 |
10933 N. Torrey Pines Rd.
La Jolla, CA 92037
US
Phone: 858-713-7300
Fax: 858-713-7400
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |